Cetuximab Intravenous and Immune globulin and hyaluronidase Subcutaneous
Determining the interaction of Cetuximab Intravenous and Immune globulin and hyaluronidase Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cetuximab
Brand name: Erbitux
Synonyms: Cetuximab
Generic Name: hyaluronidase / immune globulin
Brand name: Hyqvia
Synonyms: Hyaluronidase and immune globulin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cetuximab Intravenous-Immune Globulin Injection (IM)
- Cetuximab Intravenous-Immune Globulin Injection (IV)
- Cetuximab Intravenous-Immune Globulin Injection (Subcutaneous or IV)
- Cetuximab Intravenous-Immune Globulin Injection (Subcutaneous)
- Cetuximab Intravenous-Immune globulin intravenous and subcutaneous
- Cetuximab Intravenous-Immune globulin subcutaneous
- Immune globulin and hyaluronidase Subcutaneous-Cetylev
- Immune globulin and hyaluronidase Subcutaneous-Cetylev oral, effervescent
- Immune globulin and hyaluronidase Subcutaneous-Cevi-Bid
- Immune globulin and hyaluronidase Subcutaneous-Cevimeline
- Immune globulin and hyaluronidase Subcutaneous-Cevimeline Hydrochloride
- Immune globulin and hyaluronidase Subcutaneous-Chamomile